drugset / Trial / NCT04368650
RhBMP-2 in Intrabony Defects - A Randomized Controlled Trial
RandomizedParallel-groupTriple-blindTreatment
Summary
This study evaluated the regenerative potential of rhBMP-2 gel in intrabony defects when compared to sticky bone (control).
Timeline
- Start
- 2017-12-05
- Primary completion
- 2019-09-20
- Completion
- 2019-10-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bone Morphogenetic Protein 2 | Protein / enzyme biologic | 0.5 ug/ml | Other |